Antibodies in ADCs are used to precisely target cells for highly cytotoxic antibody compounds. Optimizing antibodies can also drastically reduce the binding of non-specific ADCs and prolong the half-life of ADCs in the blood. In early studies, the use of mouse antibodies by antibody experts and Elisa often resulted in a severe immune response, and […]